Senior Director, Market Access

<div class="content-intro"><p>Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic conditions continue to suffer - our goal is to fundamentally change the outcomes for these patients.&nbsp;</p></div><p>Alumis is seeking a high-impact Senior Director to help shape and deliver U.S. market access strategy for a late-stage immunology asset in dermatology. Reporting to the SVP of Market Access, this role is designed for someone who thrives in a lean environment, takes ownership beyond their title, and drives strategy through execution.</p> <p>You will operate as a critical member of a&nbsp;small, senior team, expected to deliver outsized impact without the infrastructure of a large organization. This role is best suited for individuals who have succeeded in complex dermatology markets and are motivated to assess issues, identify feasible solutions, make decisions, and operate with efficiency.</p> <h2><strong>Key Responsibilities:</strong></h2> <h3><strong>Strategic Leadership in a Lean Environment</strong></h3> <ul> <li>Partner directly with the SVP of Market Access to shape and refine U.S. access strategy.</li> <li>Own and drive high-priority components of pricing, payer positioning, and access execution—personally and with limited support.</li> <li>Challenge conventional approaches and bring forward differentiated strategies grounded in real-world payer behavior.</li> </ul> <h3><strong>Payer Strategy &amp; Market Impact</strong></h3> <ul> <li>Lead core elements of U.S. payer strategy, including positioning, coverage objectives, and contracting approach in highly managed, rebate-driven markets.</li> <li>Anticipate aggressive payer tactics (step edits, exclusions, reauthorization criteria) and design pragmatic, executable solutions for a small biotech.</li> <li>Engage directly with payer stakeholders and translate insights into actionable strategy.</li> </ul> <h3><strong>Value Story &amp; Evidence Translation</strong></h3> <ul> <li>Anticipate the future and develop clear, compelling payer value narratives that differentiate in crowded dermatology markets.</li> <li>Create compelling and workable outcomes contracting options that augment brand position.</li> <li>Translate clinical and economic evidence into practical tools that drive coverage decisions.</li> <li>Partner closely with HEOR and medical to ensure evidence generation is focused, efficient, and directly tied to access impact.</li> </ul> <h3><strong>Launch Execution &amp; Access Readiness</strong>